Title:
IMMUNE CELLS TARGETING EPCAM AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/236913
Kind Code:
A1
Abstract:
The present invention relates to the technical field of biomedicine, and specifically relates to immune cells targeting EpCAM and a medical use thereof. Provided is a use of immune cells in the preparation of a drug for preventing or treating a tumor; the immune cells are cells for adoptive immune cell therapy, which can target and kill EpCAM-expressing cells; and the tumor expresses EpCAM and is a metastatic tumor.
Inventors:
WANG SUQIONG (CN)
Application Number:
PCT/CN2023/098386
Publication Date:
December 14, 2023
Filing Date:
June 05, 2023
Export Citation:
Assignee:
SUZHOU IMMUNOHEAD BIOTECHNOLOGY CO LTD (CN)
International Classes:
A61K35/13; A61K39/00; A61K35/17; A61K39/395; A61P35/00; C07K16/28; C07K16/46; C07K19/00; C12N15/13; C12N15/62
Foreign References:
| CN113368262A | 2021-09-10 |
Other References:
ANONYMOUS: "New treatment for advanced digestive system malignancies: CAR-T cell therapy_Treatment_Subjects_Examination", 8 December 2021 (2021-12-08), XP093114610, Retrieved from the Internet
ANONYMOUS: "New treatment option for gastric cancer: chimeric antigen receptor-modified autologous cell therapy targeting EpCAM_Malignant Tumor_Examination_Positive", 9 December 2021 (2021-12-09), XP093114615, Retrieved from the Internet
ANONYMOUS: "New treatment option for gastric cancer: chimeric antigen receptor-modified autologous cell therapy targeting EpCAM_Malignant Tumor_Examination_Positive", 9 December 2021 (2021-12-09), XP093114615, Retrieved from the Internet
Attorney, Agent or Firm:
ZHONGLUN LAW FIRM (CN)
Download PDF:
Previous Patent: CONTAMINATED SITE IN-SITU REMEDIATION SYSTEM AND REMEDIATION METHOD
Next Patent: MULTIPLE HYPOTHESIS PREDICTION CODING
Next Patent: MULTIPLE HYPOTHESIS PREDICTION CODING